These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3036485)

  • 1. Analysis of ligand-binding to the kringle 4 fragment from human plasminogen.
    De Marco A; Petros AM; Laursen RA; Llinás M
    Eur Biophys J; 1987; 14(6):359-68. PubMed ID: 3036485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H-NMR spectroscopic manifestations of ligand binding to the kringle 4 domain of human plasminogen.
    De Marco A; Laursen RA; Llinas M
    Arch Biochem Biophys; 1986 Feb; 244(2):727-41. PubMed ID: 3004350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
    Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
    Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy.
    Thewes T; Constantine K; Byeon IJ; Llinás M
    J Biol Chem; 1990 Mar; 265(7):3906-15. PubMed ID: 2105955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR.
    Byeon IJ; Kelley RF; Mulkerrin MG; An SS; Llinás M
    Biochemistry; 1995 Mar; 34(9):2739-50. PubMed ID: 7893685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand specificity of human plasminogen kringle 4.
    Rejante MR; Byeon IJ; Llinás M
    Biochemistry; 1991 Nov; 30(46):11081-92. PubMed ID: 1657159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site.
    Motta A; Laursen RA; Llinás M; Tulinsky A; Park CH
    Biochemistry; 1987 Jun; 26(13):3827-36. PubMed ID: 2820478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance study of lysine-binding to the kringle 4 domain of human plasminogen. The structure of the binding site.
    Ramesh V; Petros AM; Llinás M; Tulinsky A; Park CH
    J Mol Biol; 1987 Dec; 198(3):481-98. PubMed ID: 2828641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1H NMR studies of aliphatic ligand binding to human plasminogen kringle 4.
    Petros AM; Ramesh V; Llinás M
    Biochemistry; 1989 Feb; 28(3):1368-76. PubMed ID: 2496756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 600 MHz H nuclear magnetic resonance studies of the kringle 4 fragment of human plasminogen.
    Hochschwender SM; Laursen RA; De Marco A; Llinas M
    Arch Biochem Biophys; 1983 May; 223(1):58-67. PubMed ID: 6305276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator.
    Byeon IJ; Kelley RF; Llinás M
    Biochemistry; 1989 Nov; 28(24):9350-60. PubMed ID: 2558718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure and functional characterization of human plasminogen kringle 5.
    Battistel MD; Grishaev A; An SS; Castellino FJ; Llinás M
    Biochemistry; 2009 Nov; 48(43):10208-19. PubMed ID: 19821587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.
    Mathews II; Vanderhoff-Hanaver P; Castellino FJ; Tulinsky A
    Biochemistry; 1996 Feb; 35(8):2567-76. PubMed ID: 8611560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains.
    Marti DN; Schaller J; Llinás M
    Biochemistry; 1999 Nov; 38(48):15741-55. PubMed ID: 10625440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macro- and micro-stabilities of the kringle 4 domain from plasminogen. The effect of ligand binding.
    De Marco A; Motta A; Llinás M; Laursen RA
    Biophys J; 1985 Sep; 48(3):411-22. PubMed ID: 4041537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 1H-NMR study of isolated domains from human plasminogen. Structural homology between kringles 1 and 4.
    Llinas M; De Marco A; Hochschwender SM; Laursen RA
    Eur J Biochem; 1983 Oct; 135(3):379-91. PubMed ID: 6311534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands.
    De Serrano VS; Castellino FJ
    Biochemistry; 1993 Apr; 32(14):3540-8. PubMed ID: 8385482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles.
    An SS; Carreño C; Marti DN; Schaller J; Albericio F; Llinas M
    Protein Sci; 1998 Sep; 7(9):1960-9. PubMed ID: 9761476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
    Anonick PK; Vasudevan J; Gonias SL
    Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive co-operative binding at two weak lysine-binding sites governs the Glu-plasminogen conformational change.
    Christensen U; Mølgaard L
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):419-25. PubMed ID: 1322132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.